Leidos forms security screening joint venture with Analogic

Leidos announced a joint venture with Altaris to combine its Security Enterprise Solutions business with Analogic, creating a U.S.-based security screening company under the Analogic brand. Leidos will contribute about 1,500 employees and $625 million of projected 2026 revenue, while retaining a significant minority stake; the transaction is expected to close in 2H 2026. The deal supports Leidos’ shift toward core growth areas and AI-native, 3D imaging security solutions, with limited but positive strategic impact on the stock.

Analysis

This is less a simple divestiture than a balance-sheet and portfolio-shape event: Leidos is monetizing a non-core asset and converting a low-growth, capex-heavy subscale business into optionality on higher-return defense IT, cyber, and federal AI work. The important second-order effect is margin mix, not revenue math — shedding an industrial-like hardware franchise should make consolidated organic growth look cleaner and improve capital allocation optics, even if near-term reported revenue steps down.

The market should also think about procurement positioning. A U.S.-based security screening platform with imaging plus AI-native/3D roadmaps is a better fit for airport, border, and critical infrastructure bids where customers increasingly want domestic supply chains and faster software refresh cycles. That can create a moat for the remaining Leidos core by reducing management distraction while improving bid credibility in adjacent homeland security and cloud/cyber programs.

The main risk is execution timing: closing is pushed out, regulatory review can surface national-security or antitrust questions, and the earnings bridge from retained ownership will be opaque until the venture’s stand-up is visible. In the next 1-2 quarters, the stock likely trades more on the cadence of contract wins and integration progress from the energy acquisition than on this transaction itself. The contrarian read is that investors may be overestimating the cash inflow: this looks more like a strategic restructuring with deferred value than an immediate liquidity event, so any valuation lift may need 6-12 months of proof.

PJT is a secondary beneficiary only through fee visibility, not earnings leverage; the more interesting read is that defense primes may increasingly use JV structures to prune slower-growth hardware while preserving vendor relationships. That could pressure smaller pure-play screening peers and suppliers if customers consolidate around a few U.S.-controlled platforms with AI-enabled upgrade paths.

Key Decisions for Investors

• Maintain/accumulate LDOS on post-announcement weakness over the next 2-6 weeks; use the transaction as a portfolio-quality catalyst, but size for a 6-12 month realization window rather than an immediate re-rate.
• Buy LDOS Jan-2027 calls or call spreads to express the view that mix improvement and core contract momentum matter more than the delayed close; target a 2:1 to 3:1 payoff if operating margin expansion shows up by mid-2026.
• Pair trade: long LDOS / short a hardware-heavy security-screening or industrial imaging peer basket on any rally, betting that domestic AI-enabled screening demand consolidates around better-capitalized platforms.
• Avoid chasing PJT on this headline; the fee is advisory and non-recurring, so any long thesis should be based on broader M&A recovery rather than this transaction specifically.
• Set a catalyst watch for the next 1-2 quarters: if LDOS integrates ENTRUST cleanly and wins another federal cyber/cloud contract, add to longs; if integration delays compress guidance, fade the move.